Eddy Johnson Owino

Eddy Johnson Owino

Auto-generated profile, based on publicly available information

Eddy Johnson Owino

Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2022 in Global Health Action
Verified
Journal Article
Open access
MMMercy Namuma Mulaku
Mercy Namuma Mulaku
BNBruce Nyagol
Bruce Nyagol
EOEddy Johnson Owino
Eddy Johnson Owino
EOEleanor Ochodo
Eleanor Ochodo
TYTaryn Young
Taryn Young
KSKaren R Steingart
Karen R Steingart
Since 2018, over 14 million people have been treated for tuberculosis (TB) globally. However, pre-treatment loss to follow-up (PTLFU) has been shown to contribute substantially to patient losses in...

19 December 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
MNMoriasi Nyanchoka
Moriasi Nyanchoka
MMMercy Mulaku
Mercy Mulaku
BNBruce Nyagol
Bruce Nyagol
EOEddy Johnson Owino
Eddy Johnson Owino
SKSimon Kariuki
Simon Kariuki
EOEleanor Ochodo
Eleanor Ochodo
The World Health Organization (WHO) model list of Essential In vitro Diagnostic (EDL) introduced in 2018 complements the established Essential Medicines List (EML) and improves its impact on advancing universal health coverage and better health outcomes. We conducted a scoping review of the literature on implementing the WHO essential lists in Africa to inform the implementation of the recently introduced EDL. We searched eight electronic databases for studies reporting on implementing the WHO EDL and EML in Africa. Two authors independently conducted study selection and data extraction, with disagreements resolved through discussion. We used the Supporting the Use of Research Evidence (SURE) framework to extract themes and synthesised findings using thematic content analysis. We used the Mixed Method Appraisal Tool (MMAT) version 2018 to assess the quality of included studies. We included 172 studies reporting on EDL and EML after screening 3,813 articles titles and abstracts and 1,545 full-text papers. Most (75%, n = 129) studies were purely quantitative in design, comprising descriptive cross-sectional designs (60%, n = 104), 15% (n = 26) were purely qualitative, and 10% (n = 17) had mixed-methods approaches. There were no qualitative or randomised experimental studies about EDL. The main barrier facing the EML and EDL was poorly equipped health facilities—including unavailability or stock-outs of essential in vitro diagnostics and medicines. Financial and non-financial incentives to health facilities and workers were key enablers in implementing the EML; however, their impact differed from one context to another. Only fifty-six (33%) of the included studies were of high quality. Poorly equipped and stocked health facilities remain an implementation barrier to essential diagnostics and medicines. Health system interventions such as financial and non-financial incentives to improve their availability can be applied in different contexts. More implementation study designs, such as experimental and qualitative studies, are required to evaluate the effectiveness of essential lists.

14 April 2024 in OSF Preprints
Verified
Preprint
Open access
SCSagam Caleb
Sagam Caleb
EOEddy Johnson Owino
Eddy Johnson Owino
LWLisa Were
Lisa Were
JOJenifer Akoth Otieno
Jenifer Akoth Otieno
MNMoriasi Nyanchoka
Moriasi Nyanchoka
EOEleanor Ochodo
Eleanor Ochodo
Background: Clinical Practice Guidelines (CPGs), serve as a framework for healthcare professionals to support therapeutic decisions and best practices for optimising patient care. However, if the guidelines do not sufficiently address all the important components of optimal care, their quality, validity, and impact are reduced. Despite multiple interventions, cases of malnutrition are still high due to the several factors linked to them. Therefore, there is a need to establish the methodological quality of malnutrition CPGs. Objective: To review and critically appraise the methodological quality of CPGs in managing malnutrition within the East African Community (EAC). Methods: We intend to focus on Integrated Management of Acute Malnutrition (IMAM) and Community Integrated Management of Malnutrition (CIMAM) guidelines. We will also focus on guidelines written in English or French and published in the last five years from the last search date or the latest guideline available. We will search the Ministry of Health websites of the EAC countries: Tanzania, Kenya, Uganda, South Sudan, Burundi, Rwanda, and the Democratic Republic of Congo. We will also search Health associations of the respective countries and their e-repositories. Using Google Search Engine, we will use the search terms "clinical practice guidelines, "nutrition guidelines", "nutrition protocols", "health guidelines"," "IMAM", "CIMAM" and "country". Five reviewers will independently select CPGs and extract data in English and French guidelines. We will conduct a quality assessment using the online version of the AGREE II tool across six domains and using the RIGHT reporting checklist. Descriptive statistics will be analysed using STATA software version 17 (Stata Corp LLC, College TX).

7 July 2022 in medRxiv
Verified
Preprint
Open access
PDF file
MNMoriasi Nyanchoka
Moriasi Nyanchoka
MMMercy Mulaku
Mercy Mulaku
BNBruce Nyagol
Bruce Nyagol
EOEddy Johnson Owino
Eddy Johnson Owino
SKSimon Kariuki
Simon Kariuki
EOEleanor Ochodo
Eleanor Ochodo
Background: The World Health Organization (WHO) model list of Essential In vitro Diagnostic (EDL) introduced in 2018 complements the established Essential Medicines List (EML) and improves its impact on advancing universal health coverage and better health outcomes. We conducted a scoping review of the literature on the implementation of the WHO essential lists in Africa to inform the implementation of the recently introduced EDL. Methods: We searched eight electronic databases for studies reporting on the implementation of the WHO EDL and EML in Africa. Two authors independently conducted study selection and data extraction, with disagreements resolved through discussion. We used the Supporting the Use of Research Evidence (SURE) framework to extract themes and synthesized findings using thematic content analysis. We used the Mixed Method Appraisal Tool (MMAT) version 2018 to assess the quality of included studies where applicable. Results: We included 172 studies reporting on EDL and EML after screening 3,813 articles titles and abstracts and 1,545 full-text papers. Most (75%, n=129) included studies were purely quantitative in design comprising descriptive cross-sectional designs (60%, n=104), 15% (n=26) were purely qualitative, and 10% (n=17) had mixed-methods approaches. There were no qualitative or randomised experimental studies about the EDL. The main barrier facing the EML and EDL was poorly equipped health facilities - including unavailability or stock-outs of essential in vitro diagnostics and medicines and inadequate infrastructure to enable health service delivery. Financial and non-financial incentives to health facilities and workers were a key enabler to the implementation of the EML however, their impact differed from one context to another. Fifty-six (33%) of the included studies were of high quality. Conclusions: The EDL implementation at the national level can learn from health system interventions to improve the availability and supply of essential medicines such as financial and non-financial incentives in different contexts. Plain language summary: The World Health Organization (WHO) periodically publishes the Model lists of essential medicines (EML) and essential in vitro diagnostics (EDL) to offer guidance to member states. The model lists help countries prioritise the critical health products that should be widely available and affordable throughout health systems. Countries frequently use these model lists to help develop their local lists of essential medicines and diagnostics. The model list of essential diagnostics was introduced in 2018, while the essential medicines were introduced 45 years ago. This work evaluates current evidence on the implementation of the more established model list of essential medicines to inform the development and implementation of the national list of essential in vitro diagnostics in Africa. We reviewed results from all available studies that looked at the provision of treatment and/or diagnostic services in Africa and assessed the barriers and enablers for their implementation. We found 172 articles assessing the provision of treatment and diagnostics in Africa. We looked in detail at the barriers and enablers to implementing the model lists of essential medicines and essential in vitro diagnostics. We also assessed the quality of the included research studies. We combined the results of the studies and established that the health system barriers were the most dominant constraints to implementing the model lists. Our review found the implementation of the established EML, the new EDL was mainly due to poorly equipped health facilities, including limited availability, and stock outs of essential medicines and tests. It is important to consider these constraints when developing and implementing the EDL at various national levels. EDL Implementation at the national level can learn from interventions to improve the availability and supply of essential medicines. Financial and non-financial incentives may be enabling interventions, but their effect varies in different countries and contexts.